Combination of treosulfan, fludarabine and cytarabine as conditioning in patients with acute myeloid leukemia, myelodysplastic syndrome and myeloproliferative neoplasms

PURPOSE: Treosulfan and fludarabine (Treo/Flu) were successfully introduced into toxicity-reduced conditioning for SCT. However, the risk of post-SCT relapse remains a matter of concern. We report the results of a novel individual treatment approach with Treo/Flu and cytarabine (Treo/Flu/AraC) condi...

Descripción completa

Detalles Bibliográficos
Autores principales: O‘Hagan Henderson, Samantha, Frietsch, Jochen J., Hilgendorf, Inken, Hochhaus, Andreas, Köhne, Claus-Henning, Casper, Jochen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article – Clinical Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470667/
https://www.ncbi.nlm.nih.gov/pubmed/34674031
http://dx.doi.org/10.1007/s00432-021-03836-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470667/
https://www.ncbi.nlm.nih.gov/pubmed/34674031
http://dx.doi.org/10.1007/s00432-021-03836-8

Ejemplares similares